CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism

Journal of Clinical Investigation

Volumn 113, Issue 2, 2004, Pages 310-317

  Dai, Zhenhua ^a   Li, Qi ^a   Wang, Yinong ^a   Gao, Ge ^a   Diggs, Lonnette S ^a   Tellides, George ^a   Lakkis, Fadi G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD30 ANTIGEN; BROXURIDINE; CD4 ANTIGEN; CYTOKINE; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; LIGAND;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; TREG CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CHEMISTRY; CYTOLOGY; HOMOZYGOTE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; NICK END LABELING; SPLEEN; TIME;

ANIMALS; ANTIGENS; ANTIGENS, CD30; ANTIGENS, CD4; ANTIGENS, CD44; APOPTOSIS; BROMODEOXYURIDINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; GRAFT REJECTION; HOMOZYGOTE; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; IN SITU NICK-END LABELING; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

EID: 85047692469     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19727     Document Type: Article

References (43)

1. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
2. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunological self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
3. + regulatory T cells constitutively expressing cycotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-309.
4. Hori, S., Nomura, T., and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
5. Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-396.
6. + T cells inhibit both induction and effector function of autoregulatory T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-1218.
7. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317-5326.
8. Shevach, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423-449.
9. Qin, S., et al. 1993. "Infectious" transplantation tolerance. Science. 259:974-977.
10. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168:1080-1086.
11. + immunoregulatory cells. J. Immunol. 167:1137-1140.
12. Lakkis, F.G., and Sayegh, M. 2003. Memory T cells: a hurdle to immunologic tolerance. J. Am. Soc. Nephrol. 44:2402-2410.
13. + T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28:3435-3447.
14. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 188:287-296.
15. Asseman, C., Mauze, S., Leach, M., Coffmann, R., and Powrie, F. 1999. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1003.
16. + T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity. 11:463-472.
17. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:629-644.
18. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190.
19. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311-323.
20. Horie, R., and Watanabe, T. 1998. CD30: expression and function in health and disease. Semin. Immunol. 10:457-470.
21. Bowen, M.A., Lee, R.K., Miragliotra, G., Nam, S.Y., and Podack, E.R. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442-449.
22. Zhang, Z.X., Yang, L., Young, K.J., DuTemple, B., and Zhang, L. 2000. Identification of a previously unknown antigen-specific regulatory T cells and its mechanism of suppression. Nat. Med. 6:782-789.
23. Amakawa, R., et al. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell. 84:551-562.
24. + T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J. Immunol. 164:4399-4407.
25. Miyawaki, S., et al. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429-434.
26. Dai, Z., Konieczny, B.T., Baddoura, F.K., and Lakkis, F.G. 1998. Impaired alloantigen-mediated T cell apoptosis and failure to induce long term allograft survival in interleukin-2-deficient mice. J. Immunol. 161:1659-1663.
27. + regulatory cells. J. Immunol. 167:107-113.
28. Chalasani, G., Dai, Z., Konieczny, B., Baddoura, F.K., and Lakkis, F.G. 2002. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. U. S. A. 99:6175-6180.
29. Lakkis, F.G., Arakelov, A., Konieczny, B.T., and Inoue, Y. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-688.
30. Dai, Z., and Lakkis, F.G. 2001. Cutting edge: secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J. Immunol. 167:6711-6715.
31. Heeger, P.S., et al. 1999. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163:2267-2275.
32. + T cell responses. J. Exp. Med. 196:1585-1592.
33. Graca, L., Cobbold, S.P., and Waldmann, H. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641-1646.
34. + regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:5558-5565.
35. +CD45RB low-density cells from untreated mice prevent acute allograft rejection. J. Immunol. 163:5353-5357.
36. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196:237-246.
37. + T cell function but not expansion. Nat. Immunol. 3:1208-1213.
38. Madakmutil, L., Maricic, I., Sercarz, E., and Kumar, V. 2003. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 170:2985-2992.
39. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
40. Lohr, J., Knoechel, B., Jiang, S., Sharpe, A.H., and Abbas, A.K. 2003. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4:664-669.
41. Akbari, O., et al. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024-1032.
42. Ansari, M.J.I., et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in NOD mice. J. Exp. Med. 198:63-69.
43. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142.